Clinical Trial: Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528196) titled 'Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome' on March 20.

Brief Summary: Acute respiratory distress syndrome (ARDS) is a common clinical syndrome in the ICU characterized by extremely high mortality and complex pathogenesis.At present, research on individualized treatment, phenotypic differences, and therapeutic efficacy in ARDS has become a hotspot.As characterized by syndrome differentiation, traditional Chinese medicine (TCM) treatment emphasizes interindividual heterogeneity and personalized management, which is expected to serve as a breakthrough in multi-target immune regulation...